Histological and clinical parameters of 2317 arrayed bladder cancer samples
| Tumors n = 2317 | Patients n = 1853 | Patients with clinical data n = 1122 | ||
|---|---|---|---|---|
| Stage | pTa | 951 | 768 | 502 |
| pT1 | 515 | 425 | 263 | |
| pT1− | 101 | 80 | 34 | |
| pT2–4 | 737 | 571 | 319 | |
| Grade | G1 | 282 | 230 | 157 |
| G2 | 987 | 792 | 467 | |
| G3 | 1048 | 831 | 498 | |
| Stage/grade | pTaG1 | 277 | 226 | 155 |
| pTaG2 | 567 | 461 | 291 | |
| pTaG3 | 107 | 81 | 56 | |
| pT1G2 | 206 | 170 | 98 | |
| pT1G3 | 309 | 255 | 165 | |
| pT2–4G2 | 186 | 140 | 69 | |
| pT2–4G3 | 551 | 431 | 250 | |
| Histology | Transitional cell carcinoma | 2108 | 1678 | 1031 |
| Squamous cell carcinoma | 73 | 59 | 34 | |
| Small cell carcinoma | 31 | 25 | 12 | |
| Adenocarcinoma | 22 | 17 | 8 | |
| Adenosquamous carcinoma | 2 | 2 | 1 | |
| Sarcomatoid carcinoma | 24 | 17 | 8 | |
| Growth pattern | Papillary | 1665 | 1367 | 867 |
| Solid | 633 | 472 | 249 | |
| No. of tumors/patient | One | 1533 | 1533 | 914 |
| Two or more | 784 | 320 | 208 | |
| Clinical endpoints | Tumor-specific survival (pT2–4) | 319 | ||
| Time to progression (pTa and pT1) | 482 | |||
| Time to recurrence (pTa and pT1) | 535 |